Forecasting The Future: 6 Analyst Projections For Nevro
Portfolio Pulse from Benzinga Insights
Nevro (NYSE:NVRO) has received mixed analyst ratings over the last three months, with 1 somewhat bullish, 4 indifferent, and 1 somewhat bearish. The average 12-month price target is now $19.00, down from $22.12. Analysts from Canaccord Genuity, RBC Capital, Truist Securities, JP Morgan, Piper Sandler, and Morgan Stanley have adjusted their ratings and price targets. Nevro's financials show a revenue growth of 3.38%, a net margin of -22.61%, an ROE of -8.09%, an ROA of -4.15%, and a debt-to-equity ratio of 0.68.
December 21, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Nevro has received a range of analyst ratings with a lowered average price target of $19.00. Financial indicators show moderate revenue growth but concerns in profitability, asset utilization, and high debt levels.
The mixed analyst ratings and lowered price target suggest uncertainty about Nevro's future performance. While the revenue growth is positive, the negative net margin, below-average ROE and ROA, and high debt-to-equity ratio may concern investors. The score is neutral due to these offsetting factors.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100